U.S. infectious disease company IPO financing 2006-2018

In 2018, R&D stage emerging infectious disease companies in the U.S. raised 111 million dollars by going public. This graph shows the amount of money companies in infectious disease in the U.S. raised through initial public offerings from 2006 to 2018, in million U.S. dollars.

Amount raised through initial public offerings (IPOs) from infectious disease companies in the U.S. from 2006 to 2018 (in million U.S. dollars)*

Money raised in million U.S. dollars
2018111
2017117
2016103
2015211
2014420
2013315
2012140
20110
2010123
20090
2008**0
2007**172
2006**202
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2019

Region

United States

Survey time period

2006 to 2018

Supplementary notes

* Figures are for US R&D-stage companies.
** Added from previous editions of the same report.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.